US5271927A
(en)
*
|
1986-02-13 |
1993-12-21 |
Celltech Limited |
Antibody conjugates with macrocyclic ligands
|
US4877868A
(en)
*
|
1986-03-12 |
1989-10-31 |
Neorx Corporation |
Radionuclide antibody coupling
|
US4965392A
(en)
*
|
1987-03-26 |
1990-10-23 |
Neorx Corporation |
Chelating compounds for metal-radionuclide labeled proteins
|
EP0284071B1
(de)
*
|
1987-03-26 |
1994-06-08 |
Neorx Corporation |
Metall-Radionuklid-markierte Proteine und Glykoproteine zur Diagnose und Therapie
|
US5091514A
(en)
*
|
1987-03-26 |
1992-02-25 |
Neorx Corporation |
Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy
|
DE3710730A1
(de)
*
|
1987-03-31 |
1988-10-20 |
Schering Ag |
Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
|
US5177192A
(en)
*
|
1987-04-02 |
1993-01-05 |
Centocor, Incorporated |
Method for labeling antibodies with a metal ion
|
JPH02504387A
(ja)
*
|
1987-04-02 |
1990-12-13 |
セントカー・カーデイオバスキユラー・イメージング・パートナーズ・エルピー |
金属イオンで抗体を標識付けする方法
|
US5053493A
(en)
*
|
1987-04-02 |
1991-10-01 |
Centocor Cardiovascular Imaging Partners, L.P. |
Method for labeling antibodies with a metal ion
|
US5021556A
(en)
*
|
1987-07-22 |
1991-06-04 |
Neorx Corporation |
Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides
|
EP0300431A3
(de)
*
|
1987-07-22 |
1990-06-27 |
Neorx Corporation |
Methode zur Bindung von radionukliden Anschwefel enthaltende Chelate
|
GB8719042D0
(en)
|
1987-08-12 |
1987-09-16 |
Parker D |
Conjugate compounds
|
AU2068588A
(en)
*
|
1987-08-12 |
1989-02-16 |
Immunomedics Inc. |
Preparation of radiolabeled conjugates
|
GB8719041D0
(en)
*
|
1987-08-12 |
1987-09-16 |
Parker D |
Conjugate compounds
|
US4933470A
(en)
*
|
1987-10-05 |
1990-06-12 |
Neorx Corporation |
Method of synthesis of vicinal diamines
|
US5648471A
(en)
*
|
1987-12-03 |
1997-07-15 |
Centocor, Inc. |
One vial method for labeling antibodies with Technetium-99m
|
EP0401302B1
(de)
*
|
1988-02-09 |
1995-06-28 |
Mallinckrodt, Inc. |
Verfahren zur herstellung eines mit metall-radionuklid-markierten proteins
|
US5202451A
(en)
*
|
1988-02-17 |
1993-04-13 |
Neorx Corporation |
Anchimeric radiometal chelating compounds
|
US5075099A
(en)
*
|
1988-05-31 |
1991-12-24 |
Neorx Corporation |
Metal radionuclide chelating compounds for improved chelation kinetics
|
US4988496A
(en)
*
|
1988-05-31 |
1991-01-29 |
Neorx Corporation |
Metal radionuclide chelating compounds for improved chelation kinetics
|
US5089249A
(en)
*
|
1988-06-10 |
1992-02-18 |
Neorx Corporation |
Conjugates for bone imaging and bone cancer therapy
|
US5202109A
(en)
*
|
1988-06-10 |
1993-04-13 |
Neorx Corporation |
Conjugates for bone imaging and bone cancer therapy
|
US5218128A
(en)
*
|
1988-06-15 |
1993-06-08 |
Centocor, Inc. |
Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
|
US4839467A
(en)
*
|
1988-06-15 |
1989-06-13 |
University Of Cincinnati |
Radioactive rhenium complexed to 2-hydroxy isobutyric acid
|
US5180816A
(en)
*
|
1988-08-24 |
1993-01-19 |
Centocor |
One vial method for labeling protein/linker conjugates with technetium-99M
|
JPH04504248A
(ja)
*
|
1988-09-30 |
1992-07-30 |
ネオロクス コーポレーション |
シッフ塩基で結合した、ターゲティング物質―診断/治療薬複合体
|
US5066789A
(en)
*
|
1988-09-30 |
1991-11-19 |
Neorx Corporation |
Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages
|
US4925650A
(en)
*
|
1988-11-16 |
1990-05-15 |
Mallinckrodt, Inc. |
Technetium -99m complex for examining the renal function
|
US5342936A
(en)
*
|
1989-02-10 |
1994-08-30 |
David Parker |
Tetra-aza macrocycles and processes for their preparation
|
DE69024826T2
(de)
*
|
1989-02-10 |
1996-06-27 |
Celltech Therapeutics Ltd |
Aza-Macrozyklen und Verfahren zu deren Herstellung
|
US5053503A
(en)
*
|
1989-02-17 |
1991-10-01 |
Centocor |
Chelating agents
|
US5206370A
(en)
|
1989-02-24 |
1993-04-27 |
Johnson Matthey, Inc. |
Certain pyridyl hydrazines and hydrazides useful for protein labeling
|
US5162240A
(en)
*
|
1989-06-16 |
1992-11-10 |
Hitachi, Ltd. |
Method and apparatus of fabricating electric circuit pattern on thick and thin film hybrid multilayer wiring substrate
|
US5247077A
(en)
*
|
1989-06-23 |
1993-09-21 |
Celltech Limited |
Tri-aza macrocycles and processes for their preparation
|
US5443816A
(en)
*
|
1990-08-08 |
1995-08-22 |
Rhomed Incorporated |
Peptide-metal ion pharmaceutical preparation and method
|
DE3930674A1
(de)
*
|
1989-09-11 |
1991-03-21 |
Diagnostikforschung Inst |
Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie
|
US5162505A
(en)
*
|
1989-09-19 |
1992-11-10 |
Centocor |
Proteins modified with positively charged carriers and compositions prepared therefrom
|
US5112953A
(en)
*
|
1989-12-29 |
1992-05-12 |
Neorx Corporation |
Radiolabeled proteins for diagnostic or therapeutic use
|
US5185433A
(en)
*
|
1990-04-09 |
1993-02-09 |
Centocor, Inc. |
Cross-linking protein compositions having two or more identical binding sites
|
GB2250198B
(en)
*
|
1990-04-18 |
1994-06-22 |
Celltech Ltd |
Tetra-aza macrocycles,processes for their preparation and their use in magnetic resonance imaging
|
US5684135A
(en)
*
|
1990-04-18 |
1997-11-04 |
Celltech Therapeutics Limited |
Conjugate compounds containing aza-macro-cycles and processes for their preparation
|
US5080883A
(en)
*
|
1990-05-11 |
1992-01-14 |
Mallinckrodt, Inc. |
99 mtcn3s-conjugated anti-bibrin monoclonal antibody as an in vivo diagnostic agent for imaging
|
US5382654A
(en)
*
|
1992-02-05 |
1995-01-17 |
Mallinckrodt Medical, Inc. |
Radiolabelled peptide compounds
|
EP0510132B1
(de)
*
|
1990-09-28 |
1997-05-14 |
Neorx Corporation |
Polymere träger zur freisetzung kovalent gebundener wirkstoffe
|
US5965107A
(en)
*
|
1992-03-13 |
1999-10-12 |
Diatide, Inc. |
Technetium-99m labeled peptides for imaging
|
US5561220A
(en)
*
|
1991-02-08 |
1996-10-01 |
Diatech, Inc. |
Technetium-99m labeled peptides for imaging inflammation
|
US6019958A
(en)
*
|
1991-02-08 |
2000-02-01 |
Diatide, Inc. |
Technetium-99m labeled peptides for imaging inflammation
|
KR930703024A
(ko)
*
|
1991-02-08 |
1993-11-29 |
리챠드 티. 딘 |
영상용 테크네튬-99m표지폴리펩티드
|
US5645815A
(en)
*
|
1991-02-08 |
1997-07-08 |
Diatide, Inc. |
Radiolabled compounds for thrombus imaging
|
US5849261A
(en)
*
|
1991-02-08 |
1998-12-15 |
Diatide, Inc. |
Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
|
US5443815A
(en)
*
|
1991-11-27 |
1995-08-22 |
Diatech, Inc. |
Technetium-99m labeled peptides for imaging
|
US6107459A
(en)
*
|
1991-02-08 |
2000-08-22 |
Diatide, Inc. |
Technetium-99m labeled peptides for diagnostic imaging
|
US5997844A
(en)
*
|
1991-02-08 |
1999-12-07 |
Diatide, Inc. |
Technetium-99m labeled peptides for imaging
|
US5736122A
(en)
*
|
1991-02-08 |
1998-04-07 |
Diatide, Inc. |
Technetium-99m labeled peptides for thrombus imaging
|
GB9113487D0
(en)
*
|
1991-06-21 |
1991-08-07 |
Amersham Int Plc |
Agents for hypoxic cells
|
US5225180A
(en)
*
|
1991-09-10 |
1993-07-06 |
Diatech, Inc. |
Technetium-99m labeled somatostatin-derived peptides for imaging
|
US5783170A
(en)
*
|
1991-11-27 |
1998-07-21 |
Diatide, Inc. |
Peptide-metal chelate conjugates
|
US5643549A
(en)
*
|
1992-02-20 |
1997-07-01 |
Rhomed Incorporated |
Leukostimulatory agent for in vivo leukocyte tagging
|
US5326856A
(en)
*
|
1992-04-09 |
1994-07-05 |
Cytogen Corporation |
Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding
|
US5508020A
(en)
|
1992-06-05 |
1996-04-16 |
Diatech, Inc. |
Technetium-99M labeled peptides for imaging
|
US5968476A
(en)
*
|
1992-05-21 |
1999-10-19 |
Diatide, Inc. |
Technetium-99m labeled peptides for thrombus imaging
|
DE4301871A1
(de)
*
|
1993-01-13 |
1994-07-14 |
Diagnostikforschung Inst |
Neue Mittel zur Diagnose von Gefäßerkrankungen
|
US5879657A
(en)
*
|
1993-03-30 |
1999-03-09 |
The Dupont Merck Pharmaceutical Company |
Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
|
DE4311023C2
(de)
*
|
1993-03-31 |
1996-05-02 |
Diagnostikforschung Inst |
Bifunktionelle chalkogenatom-unterbrochene Chelatbildner von Typ XN¶1¶S¶1¶O¶1¶ für radioaktive Isotope, deren Metallkomplexe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel
|
DE4310999C2
(de)
*
|
1993-03-31 |
1996-07-18 |
Diagnostikforschung Inst |
Bifunktionelle chalkogenatom-unterbrochene Chelatbildner vom Typ XN¶1¶S¶1¶X' für radioaktive Isotope und deren Metallkomplexe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel
|
DE4311022C2
(de)
*
|
1993-03-31 |
1996-07-11 |
Diagnostikforschung Inst |
Bifunktionelle chalkogenatom-unterbrochene Chelatbildner vom Typ S¶3¶N¶2¶ für radioaktive Isotope und deren Metallkomplexe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel
|
CA2158249A1
(en)
*
|
1993-03-31 |
1994-10-13 |
James W. Brodack |
Radiopharmaceutical formulations having non-stannous reductants
|
WO1994026294A1
(en)
*
|
1993-05-14 |
1994-11-24 |
Mallinckrodt Medical, Inc. |
Ligand precursors for incorporation into peptides
|
US5449761A
(en)
*
|
1993-09-28 |
1995-09-12 |
Cytogen Corporation |
Metal-binding targeted polypeptide constructs
|
WO1995034315A1
(en)
*
|
1994-06-16 |
1995-12-21 |
Neorx Corporation |
Radiolabeled annexin-galactose conjugates
|
US5942210A
(en)
*
|
1994-11-15 |
1999-08-24 |
Cytogen Corporation |
Methods for lyoprotecting a macromolecule using tricine
|
DE19505960A1
(de)
*
|
1995-02-21 |
1996-08-22 |
Deutsches Krebsforsch |
Konjugat zur individuellen Dosierung von Arzneimitteln
|
AU6113396A
(en)
|
1995-06-14 |
1997-01-15 |
Regents Of The University Of California, The |
Novel high affinity human antibodies to tumor antigens
|
DE19536780A1
(de)
*
|
1995-09-21 |
1997-03-27 |
Diagnostikforschung Inst |
Bifunktionelle sulfidhaltige Sulfonamid-Chelatbildner vom Typ XSNY für radioaktive Isotope
|
US6299857B1
(en)
*
|
1995-12-28 |
2001-10-09 |
The General Hospital Corporation |
Cardiovascular and thrombus imaging agents, methods and kits
|
US6187286B1
(en)
*
|
1996-12-27 |
2001-02-13 |
The General Hospital Corporation |
Tumor imaging agents, methods and kits
|
US6960457B1
(en)
|
1997-09-04 |
2005-11-01 |
Stanford University |
Reversible immobilization of arginine-tagged moieties on a silicate surface
|
EP2085781B2
(de)
|
2000-10-06 |
2020-03-11 |
Life Technologies Corporation |
Zellen mit spektralen Signaturen und Verfahren zur Herstellung und Verwendung davon
|
US20050059031A1
(en)
|
2000-10-06 |
2005-03-17 |
Quantum Dot Corporation |
Method for enhancing transport of semiconductor nanocrystals across biological membranes
|
US7378280B2
(en)
|
2000-11-16 |
2008-05-27 |
California Institute Of Technology |
Apparatus and methods for conducting assays and high throughput screening
|
US6972324B2
(en)
|
2001-05-18 |
2005-12-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Antibodies specific for CD44v6
|
EP1406493A4
(de)
|
2001-06-11 |
2006-06-14 |
Xenoport Inc |
Verabreichung von mitteln über den pept-2-transporter
|
JP4355210B2
(ja)
|
2001-11-30 |
2009-10-28 |
フルイディグム コーポレイション |
微小流体デバイスおよび微小流体デバイスの使用方法
|
US7332585B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
NZ538284A
(en)
|
2002-07-18 |
2008-04-30 |
Helix Biopharma Corp |
Use of urease and targeting molecule for inhibiting cancer cell growth
|
US20050043233A1
(en)
|
2003-04-29 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
|
GB0416062D0
(en)
*
|
2004-07-19 |
2004-08-18 |
Amersham Plc |
Improved N4 chelator conjugates
|
AU2005211385B2
(en)
|
2004-02-02 |
2008-12-11 |
Ambrx, Inc. |
Modified human growth hormone polypeptides and their uses
|
WO2006009901A2
(en)
|
2004-06-18 |
2006-01-26 |
Ambrx, Inc. |
Novel antigen-binding polypeptides and their uses
|
MX2007007590A
(es)
|
2004-12-22 |
2007-12-10 |
Ambrx Inc |
Composiciones que contienen, metodos que involucran y usos de aminoacidos no naturales y polipeptidos.
|
ATE542920T1
(de)
|
2004-12-22 |
2012-02-15 |
Ambrx Inc |
Modifiziertes menschliches wachstumshormon
|
US20090018029A1
(en)
|
2005-11-16 |
2009-01-15 |
Ambrx, Inc. |
Methods and Compositions Comprising Non-Natural Amino Acids
|
AU2007292903B2
(en)
|
2006-09-08 |
2012-03-29 |
Ambrx, Inc. |
Modified human plasma polypeptide or Fc scaffolds and their uses
|
EP2842570B1
(de)
|
2007-03-07 |
2020-05-06 |
UTI Limited Partnership |
Zusammensetzungen und verfahren zur prävention und behandlung von autoimmunkrankheiten
|
KR101476472B1
(ko)
|
2007-03-30 |
2015-01-05 |
암브룩스, 인코포레이티드 |
변형된 fgf-21 폴리펩티드 및 그 용도
|
CA2699394C
(en)
|
2007-09-17 |
2020-03-24 |
The Regents Of The University Of California |
Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
|
MX2010003099A
(es)
|
2007-09-21 |
2010-05-17 |
Univ California |
Interferon de objetivo demuestra actividades potentes apoptoticas y antitumorales.
|
NZ584825A
(en)
|
2007-11-20 |
2013-03-28 |
Ambrx Inc |
Modified insulin polypeptides and their uses
|
JP5702150B2
(ja)
|
2008-02-08 |
2015-04-15 |
アンブルックス, インコーポレイテッドAmbrx, Inc. |
修飾されているレプチンポリペプチドおよびそれらの使用
|
JP5680534B2
(ja)
|
2008-07-23 |
2015-03-04 |
イーライ リリー アンド カンパニー |
修飾されているウシg−csfポリペプチドおよびそれらの使用
|
PL2342223T3
(pl)
|
2008-09-26 |
2017-09-29 |
Ambrx, Inc. |
Zmodyfikowane polipeptydy zwierzęcej erytropoetyny i ich zastosowania
|
AU2009296267B2
(en)
|
2008-09-26 |
2013-10-31 |
Ambrx, Inc. |
Non-natural amino acid replication-dependent microorganisms and vaccines
|
ES2626327T3
(es)
|
2009-02-06 |
2017-07-24 |
The Regents Of The University Of California |
Agentes enlazantes de calcio que inducen crecimiento del cabello y/o crecimiento de las uñas
|
CN104017063A
(zh)
|
2009-12-21 |
2014-09-03 |
Ambrx公司 |
经过修饰的猪促生长素多肽和其用途
|
CN107674121A
(zh)
|
2009-12-21 |
2018-02-09 |
Ambrx 公司 |
经过修饰的牛促生长素多肽和其用途
|
CA2797033C
(en)
|
2010-04-22 |
2021-10-19 |
Longevity Biotech, Inc. |
Highly active polypeptides and methods of making and using the same
|
MX346786B
(es)
|
2010-08-17 |
2017-03-31 |
Ambrx Inc |
Polipeptidos de relaxina modificados y sus usos.
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
US11246915B2
(en)
|
2010-09-15 |
2022-02-15 |
Applied Molecular Transport Inc. |
Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
|
CN105541978B
(zh)
|
2010-09-15 |
2019-12-13 |
兰德尔·J·米斯尼 |
使用细菌毒素衍生的转运序列递送生物活性剂的系统和方法
|
AR083006A1
(es)
|
2010-09-23 |
2013-01-23 |
Lilly Co Eli |
Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
|
HUE035000T2
(en)
|
2010-09-29 |
2018-03-28 |
Uti Lp |
A method of treating autoimmune disease using biocompatible bioabsorbable nanospheres
|
US9511151B2
(en)
|
2010-11-12 |
2016-12-06 |
Uti Limited Partnership |
Compositions and methods for the prevention and treatment of cancer
|
EP2684048B1
(de)
|
2011-03-11 |
2018-10-03 |
Board of Regents of the University of Nebraska |
Biomarker für koronare herzkrankheit
|
EP2694095B1
(de)
|
2011-04-05 |
2018-03-07 |
Longevity Biotech, Inc. |
Zusammensetzungen mit glukagon-analogen sowie verfahren zu ihrer herstellung und verwendung
|
EP3170821B1
(de)
|
2011-05-27 |
2021-09-15 |
Ambrx, Inc. |
Zusammensetzungen mit, verfahren mit und verwendungen von mit nichtnatürlichen aminosäuren verknüpften dolastatin-derivaten
|
JP6581774B2
(ja)
|
2011-05-27 |
2019-09-25 |
アンブルックス, インコーポレイテッドAmbrx, Inc. |
非天然アミノ酸結合ドラスタチン誘導体を含有する化合物またはその化合物の溶媒和物、およびドラスタチンアナログを誘導体化するための方法
|
CN104159884B
(zh)
*
|
2012-02-03 |
2016-01-13 |
株式会社Lg生命科学 |
通过使用水或多种酸作为添加剂的新型麦克尔加成反应制备化合物的方法
|
US10988516B2
(en)
|
2012-03-26 |
2021-04-27 |
Uti Limited Partnership |
Methods and compositions for treating inflammation
|
AU2013270686B2
(en)
|
2012-06-07 |
2016-11-10 |
Ambrx, Inc. |
Prostate-specific membrane antigen antibody drug conjugates
|
CN104619350A
(zh)
|
2012-06-14 |
2015-05-13 |
Ambrx公司 |
结合到核受体配体多肽的抗psma抗体
|
EP2861262B1
(de)
|
2012-06-19 |
2018-11-28 |
Ambrx, Inc. |
Anti-cd70-antikörper-arzneimittelkonjugate
|
US9603948B2
(en)
|
2012-10-11 |
2017-03-28 |
Uti Limited Partnership |
Methods and compositions for treating multiple sclerosis and related disorders
|
EP2968469A4
(de)
|
2013-03-15 |
2016-08-31 |
Longevity Biotech Inc |
Peptide mit nichtnatürlichen aminosäuren und verfahren zur herstellung und verwendung davon
|
US11559580B1
(en)
|
2013-09-17 |
2023-01-24 |
Blaze Bioscience, Inc. |
Tissue-homing peptide conjugates and methods of use thereof
|
WO2015066543A1
(en)
|
2013-11-01 |
2015-05-07 |
Board Of Regents, The University Of Texas System |
Targeting her2 and her3 with bispecific antibodies in cancerous cells
|
EP3539564A1
(de)
|
2013-11-04 |
2019-09-18 |
UTI Limited Partnership |
Verfahren und zusammensetzungen für retard-immuntherapie
|
KR102598038B1
(ko)
|
2014-05-07 |
2023-11-07 |
어플라이드 몰레큘라 트랜스포트 인크. |
생물학적 활성 화물의 경구 전달용 콜릭스 독소-유래 융합 분자
|
KR102637699B1
(ko)
|
2014-10-24 |
2024-02-19 |
브리스톨-마이어스 스큅 컴퍼니 |
변형된 fgf-21 폴리펩티드 및 그의 용도
|
BR112017023853A2
(pt)
|
2015-05-06 |
2018-07-17 |
Uti Limited Partnership |
composições de nanopartícula para terapia sustentada.
|
US10193422B2
(en)
|
2015-05-13 |
2019-01-29 |
Makita Corporation |
Power tool
|
CN108348603B
(zh)
|
2015-11-03 |
2023-12-29 |
Ambrx公司 |
抗cd3叶酸结合物和其用途
|
US10946106B2
(en)
|
2015-11-30 |
2021-03-16 |
The Regents Of The University Of California |
Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
|
CA3020601A1
(en)
|
2016-04-12 |
2017-10-19 |
Blaze Bioscience, Inc. |
Methods of treatment using chlorotoxin conjugates
|
WO2017181149A1
(en)
|
2016-04-15 |
2017-10-19 |
Blaze Bioscience, Inc. |
Methods of treating breast cancer
|
EP3538153A4
(de)
|
2016-11-11 |
2020-06-24 |
The Regents of the University of California |
Anti-cd46-antikörper und verfahren zur verwendung
|
JP2020503857A
(ja)
|
2016-12-12 |
2020-02-06 |
セファイド |
自動反応カートリッジにおける統合化イムノpcr及び核酸分析
|
AU2018205458A1
(en)
|
2017-01-05 |
2019-07-11 |
The Regents Of The University Of California |
PAC1 receptor agonists (MAXCAPS) and uses thereof
|
SG11201907209QA
(en)
|
2017-02-08 |
2019-09-27 |
Bristol Myers Squibb Co |
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
|
PL3762009T3
(pl)
|
2018-03-08 |
2022-09-12 |
Applied Molecular Transport Inc. |
Pochodzące z toksyny konstrukty dostarczające do dostarczania doustnego
|
US20210015940A1
(en)
|
2018-03-29 |
2021-01-21 |
Ambrx, Inc. |
Humanized anti-prostate -specific membrane antigen (psma) antibody drug conjugates
|
MX2021002301A
(es)
|
2018-08-28 |
2021-04-28 |
Ambrx Inc |
Bioconjugados de anticuerpo-foliato anti-cd3 y sus usos.
|
PL3849614T3
(pl)
|
2018-09-11 |
2024-04-22 |
Ambrx, Inc. |
Koniugaty polipeptydu interleukiny-2 i ich zastosowania
|
CN113366015A
(zh)
|
2018-10-19 |
2021-09-07 |
Ambrx公司 |
白细胞介素-10多肽缀合物、其二聚体及其用途
|
PL3650037T3
(pl)
|
2018-11-07 |
2022-06-06 |
Applied Molecular Transport Inc. |
Konstrukty dostarczające do transcytozy i powiązane z nimi sposoby
|
EP3923991A1
(de)
|
2019-02-12 |
2021-12-22 |
Ambrx, Inc. |
Zusammensetzungen mit sowie verfahren und verwendungen von antikörper-tlr-agonist-konjugaten
|
WO2021034727A1
(en)
|
2019-08-16 |
2021-02-25 |
Applied Molecular Transport Inc. |
Compositions, formulations, and interleukin production and purification
|
WO2021173889A1
(en)
|
2020-02-26 |
2021-09-02 |
Ambrx, Inc. |
Uses of anti-cd3 antibody folate bioconjugates
|
AU2021233909A1
(en)
|
2020-03-11 |
2022-09-29 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and methods of use thereof
|
JP2023534765A
(ja)
|
2020-08-07 |
2023-08-10 |
フォーティス セラピューティクス,インク. |
免疫複合体を標的とするcd46およびその使用方法
|
KR20230073200A
(ko)
|
2020-08-20 |
2023-05-25 |
암브룩스, 인코포레이티드 |
항체-tlr 작용제 접합체, 그 방법 및 용도
|
JP2024512775A
(ja)
|
2021-04-03 |
2024-03-19 |
アンブルックス,インコーポレイテッド |
抗her2抗体薬物コンジュゲート及びその使用
|
WO2024077277A1
(en)
|
2022-10-07 |
2024-04-11 |
Ambrx, Inc. |
Drug linkers and antibody conjugates thereof
|